home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

231 rows where has_known_aptamer = 0, in_cev_map = 1 and surface_class = "A2_pm_peripheral" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

tier 2

  • Tier 1 121
  • Tier 1.5 110

has_structure 2

  • 1 185
  • 0 46

has_cryoEM 2

  • 0 187
  • 1 44

surface_class 1

  • A2_pm_peripheral · 231 ✖

in_cev_map 1

  • 1 · 231 ✖

has_known_aptamer 1

  • - · 231 ✖

has_activation_state_pdb_pair 1

  • 0 231
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
P35555 FBN1 Fibrillin-1 Tier 1 0.809 1 A2_pm_peripheral 11   0 0     0 0   1 Marfan syndrome 0.8969300970597663
P51531 SMARCA2 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 Tier 1 0.797 1 A2_pm_peripheral 31 65.06 0 0     0 0   1 intellectual disability-sparse hair-brachydactyly syndrome 0.85547142397368
P62873 GNB1 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 Tier 1 0.794 1 A2_pm_peripheral 100 97.06 1 0     0 0   1 intellectual disability, autosomal dominant 42 0.8462216225099116
P52333 JAK3 Tyrosine-protein kinase JAK3 Tier 1 0.794 1 A2_pm_peripheral 42 85.69 0 0     0 0   1 T-B+ severe combined immunodeficiency due to JAK3 deficiency 0.8450717197794638
P29400 COL4A5 Collagen alpha-5(IV) chain Tier 1.5 0.794 1 A2_pm_peripheral 2 48.12 0 0     0 0   1 X-linked Alport syndrome 0.8472963899466404
Q14315 FLNC Filamin-C Tier 1.5 0.791 1 A2_pm_peripheral 14 75.06 0 0     0 0   1 hypertrophic cardiomyopathy 26 0.8363192336142512
O75369 FLNB Filamin-B Tier 1 0.788 1 A2_pm_peripheral 23 76.25 0 0     0 0   1 Larsen syndrome 0.826975893141549
P06737 PYGL Glycogen phosphorylase, liver form Tier 1 0.787 1 A2_pm_peripheral 19 92.69 1 0     0 0   1 glycogen storage disease VI 0.8220063508118274
P49770 EIF2B2 Translation initiation factor eIF2B subunit beta Tier 1 0.787 1 A2_pm_peripheral 25 86.56 1 0     0 0   1 CACH syndrome 0.824634396744653
P21333 FLNA Filamin-A Tier 1 0.786 1 A2_pm_peripheral 26 76.56 1 0     0 0   1 Melnick-Needles syndrome 0.8200516896124751
P31040 SDHA Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial Tier 1.5 0.785 1 A2_pm_peripheral 4 93.94 1 0     0 0   1 mitochondrial complex II deficiency, nuclear type 1 0.815589203208636
O43175 PHGDH D-3-phosphoglycerate dehydrogenase Tier 1 0.784 1 A2_pm_peripheral 21 92.94 0 0     0 0   1 PHGDH deficiency 0.8128323162948055
Q9Y3Z3 SAMHD1 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Tier 1 0.783 1 A2_pm_peripheral 76 88.19 0 0     0 0   1 Aicardi-Goutières syndrome 0.8101030032946703
Q8TD16 BICD2 Protein bicaudal D homolog 2 Tier 1 0.782 1 A2_pm_peripheral 2 78.0 0 0     0 0   1 autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures 0.8072433385790271
Q08499 PDE4D 3',5'-cyclic-AMP phosphodiesterase 4D Tier 1 0.782 1 A2_pm_peripheral 100 67.44 0 0     0 0   1 acrodysostosis 2 with or without hormone resistance 0.8053064772512085
Q01831 XPC DNA repair protein complementing XP-C cells Tier 1 0.782 1 A2_pm_peripheral 14 66.56 1 0     0 0   1 Xeroderma pigmentosum complementation group C 0.8056391472748724
O95630 STAMBP STAM-binding protein Tier 1.5 0.782 1 A2_pm_peripheral 5 84.0 0 0     0 0   1 microcephaly-capillary malformation syndrome 0.8060251236043802
Q96BN8 OTULIN Ubiquitin thioesterase otulin Tier 1 0.781 1 A2_pm_peripheral 12 83.81 0 0     0 0   1 autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive 0.804614072482804
Q12840 KIF5A Kinesin heavy chain isoform 5A Tier 1.5 0.781 1 A2_pm_peripheral 4 75.31 1 0     0 0   1 hereditary spastic paraplegia 10 0.8029405627392309
O00330 PDHX Pyruvate dehydrogenase protein X component, mitochondrial Tier 1.5 0.779 1 A2_pm_peripheral 5 77.31 1 0     0 0   1 pyruvate dehydrogenase E3-binding protein deficiency 0.7957753555992844
Q9NQG7 HPS4 BLOC-3 complex member HPS4 Tier 1.5 0.779 1 A2_pm_peripheral 1 61.66 1 0     0 0   1 Hermansky-Pudlak syndrome with pulmonary fibrosis 0.7967575753847002
P49773 HINT1 Adenosine 5'-monophosphoramidase HINT1 Tier 1 0.777 1 A2_pm_peripheral 59 96.19 0 0     0 0   1 Autosomal recessive axonal neuropathy with neuromyotonia 0.7895184274923306
P12814 ACTN1 Alpha-actinin-1 Tier 1.5 0.777 1 A2_pm_peripheral 4 85.25 0 0     0 0   1 platelet-type bleeding disorder 15 0.7887662502912471
O00468 AGRN Agrin Tier 1.5 0.777 1 A2_pm_peripheral 1 68.81 1 0     0 0   1 congenital myasthenic syndrome 8 0.7912009864338403
Q9Y263 PLAA Phospholipase A-2-activating protein Tier 1 0.77 1 A2_pm_peripheral 5 84.0 0 0     0 0   1 neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies 0.7656265019633831
Q9NWZ3 IRAK4 Interleukin-1 receptor-associated kinase 4 Tier 1 0.768 1 A2_pm_peripheral 96 83.94 0 0     0 0   1 immunodeficiency 67 0.7593923638641371
Q9BYI3 HYCC1 Hyccin Tier 1 0.766 1 A2_pm_peripheral 5 67.75 1 0     0 0   1 Hypomyelination - congenital cataract 0.7528702184568328
Q9NZ09 UBAP1 Ubiquitin-associated protein 1 Tier 1.5 0.764 1 A2_pm_peripheral 3 62.5 0 0     0 0   1 spastic paraplegia 80, autosomal dominant 0.7464670113492812
Q01484 ANK2 Ankyrin-2 Tier 1 0.762 1 A2_pm_peripheral 11 61.78 0 0     0 0   1 Romano-Ward syndrome 0.7390647393986454
Q6NZI2 CAVIN1 Caveolae-associated protein 1 Tier 1.5 0.76 1 A2_pm_peripheral 3 67.38 0 0     0 0   1 congenital generalized lipodystrophy type 4 0.7317728549444928
Q92997 DVL3 Segment polarity protein dishevelled homolog DVL-3 Tier 1.5 0.759 1 A2_pm_peripheral 9 58.91 0 0     0 0   1 autosomal dominant Robinow syndrome 0.7284158836126389
P13797 PLS3 Plastin-3 Tier 1 0.757 1 A2_pm_peripheral 6 88.75 1 0     0 0   1 X-linked osteoporosis with fractures 0.721756781312783
P07948 LYN Tyrosine-protein kinase Lyn Tier 1 0.754 1 A2_pm_peripheral 6 83.12 0 0     0 0   1 autoinflammatory disease, systemic, with vasculitis 0.7119500711989845
P22735 TGM1 Protein-glutamine gamma-glutamyltransferase K Tier 1.5 0.754 1 A2_pm_peripheral 1 84.12 0 0     0 0   1 autosomal recessive congenital ichthyosis 0.714755023666953
P31939 ATIC Bifunctional purine biosynthesis protein ATIC Tier 1.5 0.754 1 A2_pm_peripheral 5 97.38 0 0     0 0   1 AICA-ribosiduria 0.7137167364484167
O15117 FYB1 FYN-binding protein 1 Tier 1 0.752 1 A2_pm_peripheral 3 56.59 0 0     0 0   1 thrombocytopenia 3 0.7067701415491194
P07357 C8A Complement component C8 alpha chain Tier 1 0.75 1 A2_pm_peripheral 11 78.69 1 0     0 0   1 Immunodeficiency due to a late component of complements deficiency 0.700643416115894
Q9Y5K6 CD2AP CD2-associated protein Tier 1 0.749 1 A2_pm_peripheral 12 62.22 0 0     0 0   1 focal segmental glomerulosclerosis 0.6952333377860125
Q8IZQ1 WDFY3 WD repeat and FYVE domain-containing protein 3 Tier 1 0.748 1 A2_pm_peripheral 2   0 0     0 0   1 Autosomal dominant microcephaly 0.6934322596452817
Q8IXK2 GALNT12 Polypeptide N-acetylgalactosaminyltransferase 12 Tier 1.5 0.748 1 A2_pm_peripheral 1 93.5 0 0     0 0   1 colorectal cancer, susceptibility to, 1 0.6932727729787528
Q96CW1 AP2M1 AP-2 complex subunit mu Tier 1 0.741 1 A2_pm_peripheral 4 89.19 0 0     0 0   1 intellectual developmental disorder 60 with seizures 0.6712897942723018
O43516 WIPF1 WAS/WASL-interacting protein family member 1 Tier 1.5 0.737 1 A2_pm_peripheral 4 58.5 0 0     0 0   1 Wiskott-Aldrich syndrome 0.6561328889736038
P48730 CSNK1D Casein kinase I isoform delta Tier 1 0.732 1 A2_pm_peripheral 46 81.0 0 0     0 0   1 Familial advanced sleep-phase syndrome 0.6394614732145313
P27815 PDE4A 3',5'-cyclic-AMP phosphodiesterase 4A Tier 1 0.732 1 A2_pm_peripheral 5 64.5 0 0     0 0   1 psoriasis 0.6394621747004946
Q12929 EPS8 Epidermal growth factor receptor kinase substrate 8 Tier 1.5 0.731 1 A2_pm_peripheral 2 70.31 0 0     0 0   1 autosomal recessive nonsyndromic hearing loss 102 0.6354471967036509
Q5VST9 OBSCN Obscurin Tier 1 0.73 1 A2_pm_peripheral 25   0 0     0 0   1 Abnormality of the skeletal system 0.6328288822708418
Q9NZ56 FMN2 Formin-2 Tier 1.5 0.729 1 A2_pm_peripheral 2 49.97 0 0     0 0   1 autosomal recessive non-syndromic intellectual disability 0.6298956049368037
P11233 RALA Ras-related protein Ral-A Tier 1 0.723 1 A2_pm_peripheral 16 89.31 0 0     0 0   1 Hiatt-Neu-Cooper neurodevelopmental syndrome 0.6092132376035464
Q16186 ADRM1 Proteasomal ubiquitin receptor ADRM1 Tier 1 0.722 1 A2_pm_peripheral 21 62.28 0 0     0 0   1 multiple myeloma 0.6073517074927846
Q96RT1 ERBIN Erbin Tier 1 0.719 1 A2_pm_peripheral 11 55.66 0 0     0 0   1 cancer 0.5976773185991211

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 1789.719ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target